Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer

Go back to Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer
InfoTech USA, Inc. (NASDAQ: FTH) Delayed: 20.57 -0.22 (1.06%)
Previous Close $20.79    52 Week High $0.25 
Open $20.84    52 Week Low $0.25 
Day High $21.97    P/E N/A 
Day Low $20.32    EPS $0.00 
Volume 182,673